These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 1354540

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
    Li Q, Feenstra M, Pfaffendorf M, Eijsman L, van Zwieten PA.
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):451-6. PubMed ID: 9156353
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ, Barnes JC, Drew GM, Clark KL, Marshall FH, Michel A, Middlemiss D, Ross BC, Scopes D, Dowle MD.
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [Abstract] [Full Text] [Related]

  • 5. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
    Li Q, Pfaffendorf M, van Zwieten PA.
    Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of aminopeptidase inhibitors on angiotensin-induced pressor responses.
    Sullivan MJ, Harding JW, Wright JW.
    Brain Res; 1988 Jul 26; 456(2):249-53. PubMed ID: 3208081
    [Abstract] [Full Text] [Related]

  • 7. Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria.
    Li Q, Zhang J, Pfaffendorf M, van Zwieten PA.
    Br J Pharmacol; 1996 Aug 26; 118(7):1653-8. PubMed ID: 8842428
    [Abstract] [Full Text] [Related]

  • 8. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
    Abhold RH, Sullivan MJ, Wright JW, Harding JW.
    J Pharmacol Exp Ther; 1987 Sep 26; 242(3):957-62. PubMed ID: 3656120
    [Abstract] [Full Text] [Related]

  • 9. Amastatin and bestatin-induced dipsogenicity in the Sprague-Dawley rat.
    Quirk WS, Harding JW, Wright JW.
    Brain Res Bull; 1987 Jul 26; 19(1):145-7. PubMed ID: 3651838
    [Abstract] [Full Text] [Related]

  • 10. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW, Roberts KA, Cook VI, Murray CE, Sardinia MF, Harding JW.
    Brain Res; 1990 Apr 23; 514(1):5-10. PubMed ID: 2357530
    [Abstract] [Full Text] [Related]

  • 11. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W, Mauz AB, Van Meel JC, Entzeroth M.
    Mol Pharmacol; 1992 Jun 23; 41(6):1081-8. PubMed ID: 1614410
    [Abstract] [Full Text] [Related]

  • 12. Intracerebroventricularly applied peptidase inhibitors increase endogenous angiotensin levels.
    Batt CM, Jensen LL, Hanesworth JM, Harding JW, Wright JW.
    Brain Res; 1990 Oct 08; 529(1-2):126-30. PubMed ID: 2282487
    [Abstract] [Full Text] [Related]

  • 13. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.
    Fortin JP, Gera L, Bouthillier J, Stewart JM, Adam A, Marceau F.
    J Pharmacol Exp Ther; 2005 Sep 08; 314(3):1169-76. PubMed ID: 15919764
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological classification of alpha 1-adrenoceptors mediating contractions of rabbit isolated ear artery: comparison with rat isolated thoracic aorta.
    Fagura MS, Lydford SJ, Dougall IG.
    Br J Pharmacol; 1997 Jan 08; 120(2):247-58. PubMed ID: 9117117
    [Abstract] [Full Text] [Related]

  • 15. Pressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran.
    Batt CM, Klein EW, Harding JW, Wright JW.
    Brain Res Bull; 1988 Nov 08; 21(5):731-5. PubMed ID: 3219604
    [Abstract] [Full Text] [Related]

  • 16. Effects of angiotensin II antagonists on the contractile and hydrosmotic effect of AT II and AT III in the toad (Bufo arenarum).
    Peral de Bruno M, Coviello A.
    J Comp Physiol B; 1996 Nov 08; 165(7):565-70. PubMed ID: 8617893
    [Abstract] [Full Text] [Related]

  • 17. Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
    le Tran Y, Forster C.
    Can J Physiol Pharmacol; 1996 Dec 08; 74(12):1277-86. PubMed ID: 9047036
    [Abstract] [Full Text] [Related]

  • 18. The effects of the aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain.
    Harding JW, Felix D.
    Brain Res; 1987 Oct 27; 424(2):299-304. PubMed ID: 3676828
    [Abstract] [Full Text] [Related]

  • 19. Vascular reactivity of isolated thoracic aorta of the C57BL/6J mouse.
    Russell A, Watts S.
    J Pharmacol Exp Ther; 2000 Aug 27; 294(2):598-604. PubMed ID: 10900237
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues.
    Pendleton RG, Gessner G, Horner E.
    J Pharmacol Exp Ther; 1991 Feb 27; 256(2):614-20. PubMed ID: 1993998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.